Efficacy and safety of first-line treatment for metastatic triple-negative breast cancer: A network meta-analysis

Efficacy and safety of first-line treatment for metastatic triple-negative breast cancer: A network meta-analysis

Background: Metastatic triple-negative breast cancer (mTNBC) is an aggressive histological subtype with poor prognosis. Several first-line treatments are currently available for mTNBC. This study conducted a network meta-analysis to compare these first-line regimens and to determine the regimen with...

Full description

Bibliographic Details
Main Authors: Mingqiang Shi, Zhoujuan Li, Guoshuang Shen, Tianzhuo Wang, Jinming Li, Miaozhou Wang, Zhen Liu, Fuxing Zhao, Dengfeng Ren, Jiuda Zhao
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:Cancer Pathogenesis and Therapy
Subjects:
Metastatic triple-negative breast cancer
First-line treatment
Chemotherapy
Immune-checkpoint inhibitors
Poly (ADP-Ribose) polymerase inhibitors
AKT inhibitor
Online Access:http://www.sciencedirect.com/science/article/pii/S2949713223000290

Internet

http://www.sciencedirect.com/science/article/pii/S2949713223000290

Similar Items